Early research (Phase 1)Ended earlyNCT04751383
What this trial is testing
Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma
Who this might be right for
High Risk NeuroblastomaRecurrent NeuroblastomaRecurrent Osteosarcoma+2 more
National Cancer Institute (NCI) 12